IMMVF
Price
$0.15
Change
-$0.02 (-11.76%)
Updated
Feb 8 closing price
Capitalization
4.96M
NAYA
Price
$1.83
Change
-$0.27 (-12.86%)
Updated
Apr 4 closing price
Capitalization
1.12M
Ad is loading...

IMMVF vs NAYA

Header iconIMMVF vs NAYA Comparison
Open Charts IMMVF vs NAYABanner chart's image
Immunovia AB
Price$0.15
Change-$0.02 (-11.76%)
Volume$325
Capitalization4.96M
NAYA Biosciences
Price$1.83
Change-$0.27 (-12.86%)
Volume$30.18K
Capitalization1.12M
IMMVF vs NAYA Comparison Chart
Loading...
NAYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMMVF vs. NAYA commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMVF is a Hold and NAYA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 06, 2025
Stock price -- (IMMVF: $0.15 vs. NAYA: $1.83)
Brand notoriety: IMMVF and NAYA are both not notable
IMMVF represents the Medical Specialties, while NAYA is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMVF: 100% vs. NAYA: 105%
Market capitalization -- IMMVF: $4.96M vs. NAYA: $1.12M
IMMVF [@Medical Specialties] is valued at $4.96M. NAYA’s [@Biotechnology] market capitalization is $1.12M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMVF’s FA Score shows that 0 FA rating(s) are green whileNAYA’s FA Score has 1 green FA rating(s).

  • IMMVF’s FA Score: 0 green, 5 red.
  • NAYA’s FA Score: 1 green, 4 red.
According to our system of comparison, NAYA is a better buy in the long-term than IMMVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAYA’s TA Score shows that 5 TA indicator(s) are bullish.

  • NAYA’s TA Score: 5 bullish, 3 bearish.

Price Growth

IMMVF (@Medical Specialties) experienced а 0.00% price change this week, while NAYA (@Biotechnology) price change was -8.50% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -6.38%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -1.88%.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.

Industries' Descriptions

@Medical Specialties (-6.38% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Biotechnology (-11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMMVF($4.96M) has a higher market cap than NAYA($1.12M). IMMVF YTD gains are higher at: 0.000 vs. NAYA (-81.173). NAYA has higher annual earnings (EBITDA): -5.58M vs. IMMVF (-146.67M). IMMVF has more cash in the bank: 68.2M vs. NAYA (472K). NAYA has less debt than IMMVF: NAYA (5.34M) vs IMMVF (35.9M). NAYA has higher revenues than IMMVF: NAYA (6.23M) vs IMMVF (1.48M).
IMMVFNAYAIMMVF / NAYA
Capitalization4.96M1.12M444%
EBITDA-146.67M-5.58M2,630%
Gain YTD0.000-81.173-
P/E RatioN/A1.30-
Revenue1.48M6.23M24%
Total Cash68.2M472K14,449%
Total Debt35.9M5.34M673%
FUNDAMENTALS RATINGS
IMMVF vs NAYA: Fundamental Ratings
IMMVF
NAYA
OUTLOOK RATING
1..100
2279
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6898
P/E GROWTH RATING
1..100
10030
SEASONALITY SCORE
1..100
30n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMMVF's Valuation (38) in the null industry is in the same range as NAYA (59). This means that IMMVF’s stock grew similarly to NAYA’s over the last 12 months.

IMMVF's Profit vs Risk Rating (100) in the null industry is in the same range as NAYA (100). This means that IMMVF’s stock grew similarly to NAYA’s over the last 12 months.

IMMVF's SMR Rating (97) in the null industry is in the same range as NAYA (100). This means that IMMVF’s stock grew similarly to NAYA’s over the last 12 months.

IMMVF's Price Growth Rating (68) in the null industry is in the same range as NAYA (98). This means that IMMVF’s stock grew similarly to NAYA’s over the last 12 months.

NAYA's P/E Growth Rating (30) in the null industry is significantly better than the same rating for IMMVF (100). This means that NAYA’s stock grew significantly faster than IMMVF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NAYA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NAYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WAFDP16.280.10
+0.62%
WaFd
MAGN17.07N/A
N/A
Magnera Corporation
AMPH26.61-0.63
-2.31%
Amphastar Pharmaceuticals
ONTO104.44-5.39
-4.91%
Onto Innovation
CEVA21.28-1.27
-5.63%
CEVA

IMMVF and

Correlation & Price change

A.I.dvisor tells us that IMMVF and IDTA have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMVF and IDTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMVF
1D Price
Change %
IMMVF100%
N/A
IDTA - IMMVF
8%
Poorly correlated
N/A
LZAGF - IMMVF
8%
Poorly correlated
-12.56%
LZAGY - IMMVF
6%
Poorly correlated
-5.29%
NAYA - IMMVF
4%
Poorly correlated
-12.86%
IRME - IMMVF
4%
Poorly correlated
N/A
More

NAYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAYA has been loosely correlated with VNDA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NAYA jumps, then VNDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAYA
1D Price
Change %
NAYA100%
-12.86%
VNDA - NAYA
37%
Loosely correlated
-5.26%
RANI - NAYA
29%
Poorly correlated
-6.92%
KPTI - NAYA
28%
Poorly correlated
N/A
SSKN - NAYA
25%
Poorly correlated
-1.19%
VYNE - NAYA
24%
Poorly correlated
-6.59%
More